Previous 10 | Next 10 |
home / stock / bayzf / bayzf news
Bayer (OTCPK:BAYZF) is scheduled to announce Q4 earnings results on Tuesday, Mar. 1, before market open. The consensus revenue estimate is $11.86B. Over the last 1 year, BAYZF has beaten EPS estimates 100% of the time and has beaten revenue estimates 100% of the time. This month, SA contribut...
The Investigator Trust returned 13% in 2021, largely due to strong performances by our energy shares. Right now, we have the trifecta – a stock, real estate and bond market bubble, all driven by the lowest interest rates in history and massive government spending. Many indi...
Private equity firm Cinven is said near an agreement to Bayer AG's (OTCPK:BAYZF) pest control business. Cinven won out over other investment firms for Bayer's Environmental Science Professional unit and a transaction may be announced as soon as this week, according to a Bloomberg report. ...
100s of companies run trials in Ukraine; some of them will face delays. In the long term, Ukraine may cease to be a favored location for clinical trials. However, neither Russia nor Ukraine are drug manufacturing hubs, and market exposure is minimal. For further details see:...
In light of the UK government's "Global Britain" agenda, the focus on striking new free trade agreements with major global economies is a key priority for the current UK administration in 2022. Developments in sustainable AgriTech, crucial to Brazil's agricultural revolution, could ho...
Inflation concerns have started to affect market sentiment, but it is highly uncertain if that will lead to a real market correction or just some short-term dips. I am continuing my monthly investment plans while still awaiting a real market correction or possibly a real crash once ma...
Bayer (OTCPK:BAYZF) is raising peak sales expectation for Nubeqa (darolutamide) after the drug, in combination with other therapies, increased overall survival (OS) in patients with metastatic hormone-sensitive prostate cancer (mHSPC) in a phase 3 trial called ARASENS. The comp...
Demand for fresh water is outrunning supply as the result of aquifer and reservoir depletion; farmers are having to cut back. At the same time, crops are coming under stress as the result of climate change / global warming and sustained droughts. For growth, value, and income, inv...
Bayer (OTCPK:BAYZF) said the U.S. Food and Drug Administration granted fast track designation to its investigational drug asundexian (BAY2433334) as a potential therapy for secondary prevention in patients with a non-cardioembolic ischemic stroke. The company is also developing asundexia...
Evotec SE (EVO -16.5%) has regained the rights to eliapixant (BAY1817080) from Bayer (OTCPK:BAYZF) who has decided to discontinue development. The P2X3 antagonist was in phase 2 for several indications: endometriosis, chronic cough, overactive bladder, and neuropathic pain. Eliapixant was par...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG Registered Shares Company Name:
BAYZF Stock Symbol:
OTCMKTS Market:
NORTHAMPTON, MA / ACCESSWIRE / August 29, 2023 / Bayer - As climate change quickens, societal expectations increase and the threat of resistance grows, new crop protection solutions are imperative. Advances in the life sciences and data-driven technologies hold the key to expanding our pipeline ...
Monsanto Must Face Georgia State Jurors in Lawsuit Over Cancer-Causing Roundup Herbicide PR Newswire 11th Circuit opinion finds chemical giant subject to state's warning label laws Nachawati Law Group trial lawyers gearing up for next Roundup cancer trial in Au...
Bayer Runs Out of Appeals at US Supreme Court as Thousands of Cancer Lawsuits Await over Roundup Herbicide PR Newswire Fears Nachawati trial lawyers gearing up for next Roundup cancer trial in August WASHINGTON , June 22, 2022 /PRNewswire/ -- Baye...